Polymorphism rs2327430 in TCF21 predicts the risk and prognosis of gastric cancer by affecting the binding between TFAP2A and TCF21
Authors:
Open Access
- 7 May 2024
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 24 (1) , 1-14
Abstract
Background: Single nuclear polymorphisms (SNPs) have been published to be correlated with multiple diseases. Transcription Factor 21 (TCF21) is a critical transcription factor involved in various types of cancers. However, the association of TCF21 genetic polymorphisms with gastric cancer (GC) susceptibility and prognosis remains unclear.Methods: A case-control study comprising 890 patients diagnosed with GC and an equal number of cancer-free controls was conducted. After rigorous statistical analysis, molecular experiments were carried out to elucidate the functional significance of the SNPs in the context of GC.Results: TCF21 rs2327430 (OR = 0.78,P = 0.026) provides protection against GC, while rs4896011 (OR = 1.39,P = 0.005) exhibit significant associations with GC risk. Furthermore, patients with the (TC + CC) genotype of rs2327430 demonstrate a relatively favorable prognosis (OR = 0.47,P = 0.012). Mechanistically, chromatin immunoprecipitation assay and luciferase reporter assay revealed that the C allele of rs2327430 disrupts the binding of Transcription Factor AP-2 Alpha (TFAP2A) to the promoter region of TCF21, resulting in increased expression of TCF21 and inhibition of malignant behaviors in GC cells.Conclusion: Our findings highlight the significant role of TCF21 SNPs in both the risk and prognosis of GC and provide valuable insights into the underlying molecular mechanisms. Specifically, the disruptive effect of rs2327430 on TCF21 expression and its ability to modulate malignant cell behaviors suggest that rs2327430 may serve as a potential predictive marker for GC risk and prognosis.Keywords
Funding Information
- Jiangsu Province Capability Improvement Project through Science, Technology and Education (ZDXK202222)
- The National Natural Science Foundation of China (81874219)
- the Project of Cultivating Innovation in Science and Technology Plan of Liyang City (LC2021001)
This publication has 57 references indexed in Scilit:
- Polymorphisms of an oncogenic gene, mesothelin, predict the risk and prognosis of gastric cancer in a Chinese Han populationArchives of Toxicology, 2022
- Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I‐II gastric cancer after curative gastrectomyCancer Medicine, 2019
- Silent but significant - A synonymous SNV alters prognosis in Pompe diseaseEBioMedicine, 2019
- SNP mutation‐related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA databaseCancer Medicine, 2019
- TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancerGene, 2019
- TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migrationMolecular Oncology, 2017
- Osteopontin splice variants and polymorphisms in cancer progression and prognosisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2017
- The Role of the Immune System Beyond the Fight Against Infection2017
- IFRD1 polymorphisms and gastric cancer risk in a Chinese populationMedical Oncology, 2014
- Gene-environment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women’s Health Initiative SHARe StudyHuman Genetics, 2012